CLRX

CollabRx and OncoDNA Partner in Molecular Diagnostics

[at noodls] – San Francisco, Calif., April 4, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and OncoDNA, SA, a Belgium company that … moreView todays social media effects on CLRXView the latest stocks trending across Twitter. Click to view dashboardSee who CollabRx is hiring next, click here to […]

TEGAL ANNOUNCES CONTINUING DISCUSSIONS FOR BALANCE OF NANOLAYER DEPOSITION PATENT PORTFOLIO

[at noodls] – February 14, 2012 Petaluma, Calif., February 14, 2012 – Tegal Corporation (NASDAQ-CM: TGAL) today announced renewed efforts to make available the balance of its semiconductor process-related intellectual … moreView todays social media effects on CLRXView the latest stocks trending across Twitter. Click to view dashboardSee who CollabRx is hiring next, click here to view […]

CollabRx to Present at Biotech Showcaseâ„¢ 2013

[Business Wire] – CollabRx, Inc. , a data analytics company focused on genomics, today announced that Chairman and CEO Thomas R. Mika is scheduled to present at Biotech Showcaseâ„¢ 2013 on Wednesday, January 9, 2013, at 2:45 p.m. moreView todays social media effects on CLRXView the latest stocks trending across Twitter. Click to view dashboardSee who CollabRx is hiring next, […]

CollabRx to Present at 6th Annual OneMedForum Conference

[Business Wire] – CollabRx, Inc. , a data analytics company focused on genomics, today announced that Chairman and CEO Thomas R. Mika is scheduled to present at the 6th Annual OneMedForum conference on Wednesday, January 9, 2013, at 10:20 a.m. moreView todays social media effects on CLRXView the latest stocks trending across Twitter. Click to view dashboardSee who CollabRx is […]